Dafalgan and jaundice Patient Reports February 10, 2010

Dafalgan Side Effects Report #5117233-1
Dafalgan side effect was reported by a Consumer or non-health professional from FRANCE on July 28, 2006. Female patient, 68 years of age, weighting 207.2 lb, was diagnosed with pyelonephritis and was treated with Dafalgan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, hepatitis , hyperbilirubinaemia, jaundice . Dafalgan dosage: unknown. During the same period patient was treated with OFLOCET, BISOPROLOL FUMARATE, RIFADIN, AMLOR, TAREG, ORACEFAL. Patient was hospitalized. Patient recovered.